Should myeloma patients be tested further if they have excellent responses to initial treatment? (https://www.myeloma.org/videos/should-myeloma-patients-be-tested-further-if-they-have-excellent-responses-initial-treatment)
In this week’s video, Dr. Brian G.M. Durie explains which tests should be used to monitor the possible progression of myeloma.
The BOTTOM LINE: Even if your myeloma protein is at a low level, set up a protocol for ongoing monitoring.
If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected] (mailto:[email protected]).
To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected] (mailto:[email protected]).
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.